Clinical Trial Update: Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease [Phase 1]

View source ↗

Summary

This Phase 1 trial is evaluating nebulized human amniotic fluid in patients with interstitial lung disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Drugs mentioned

• Nebulized human amniotic fluid

Snippet

Sponsor: Maule Stem Cell Research Institute, Inc. | Conditions: Lung Diseases, Interstitial | Phase 1 | Status: RECRUITING